International Student Vaccination Information

Our vaccination and travel policies are currently being written according to changing United Stated CDC guidelines, so please keep checking back to ensure you have the most current information.

  • We highly recommend that students obtain an FDA-authorized or World Health Organization (WHO)–listed COVID-19 vaccine prior to their arrival in Maine.   
  • Students who were vaccinated outside the United States with an FDA-authorized COVID-19 or WHO-listed vaccine and who have received all the recommended doses do not need any additional doses to meet Bowdoin’s vaccination requirement. And, if they arrive in Maine more than two weeks after their final dose, they are not required to quarantine in the United States prior to the start of their program. 
  • Students not able to obtain an FDA-authorized or WHO–listed vaccine prior to their arrival in Maine must quarantine in the United States for seven days prior to the start of their program.  International student Orientation begins on Sunday, August 22, so the mandatory quarantine would need to begin on Sunday, August 15.  If you do need to quarantine in the United States we hope to be able to offer students the ability to quarantine on campus, but we are still determining if that will be possible. Viral testing will be part of the quarantine requirements. 
  • Unvaccinated or under-vaccinated students will be required to receive an FDA-authorized COVID-19 vaccine shortly after arrival. 

Vaccination and Quarantine Requirement Specifics for International Students  

  • Students who have received all of the recommended doses of a COVID-19 vaccine that is not currently FDA-authorized but has been listed for emergency use by the World Health Organization (WHO):
    • Do not need any additional doses of an FDA-authorized COVID-19 vaccine. 
    • If it has been more than two weeks after their final dose, students are not required to quarantine in Maine prior to the start of their program. 
  • Students who have received their first dose of an FDA-authorized COVID-19 vaccine that requires two doses, but who have not received their second dose:  
    • Do not need to restart the vaccine series in the United States, but should make arrangements to receive the second dose as close to the recommended time as possible.  
    • Upon arrival in the US, these individuals must quarantine for seven days as indicated above.   
    • Only people who have received all recommended doses of an FDA-authorized or WHO-listed COVID-19 vaccine and are two weeks past their final dose are considered fully vaccinated for the purpose of public health guidance. 
  • Students who have not received all the recommended doses of a COVID-19 vaccine listed for emergency use by the WHO, but not by the FDA:
    • May be offered a complete FDA-authorized COVID-19 vaccine series. Note: There are no data available on the safety or efficacy of receiving a COVID-19 vaccine currently authorized in the United States after receipt of a non-FDA-authorized COVID-19 vaccine. And, the minimum interval between the last dose of a non-FDA authorized vaccine or a WHO-listed vaccine and an FDA-authorized COVID-19 vaccine is twenty-eight days. 
    • Must quarantine in the United States for seven days prior to the start of their program as indicated above. 
  • Students who have received a COVID-19 vaccine that is neither authorized by FDA nor listed for emergency use by WHO: 
    • May be offered a complete series of an FDA-authorized COVID-19 vaccine. Note: There are no data available on the safety or efficacy of receiving a COVID-19 vaccine currently authorized in the United States after receipt of a non-FDA-authorized COVID-19 vaccine. And, the minimum interval between the last dose of a non-FDA authorized vaccine or a WHO-listed vaccine and an FDA-authorized COVID-19 vaccine is twenty-eight days.
    • Must quarantine in the United States for seven days prior to the start of their program as indicated above.